Funder
National Institutes of Health
U.S. Department of Defense
Sigrid Juséliuksen Säätiö
Päivikki ja Sakari Sohlbergin Säätiö
Finska Läkaresällskapet
Academy of Finland
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Abshagen K, Konig M, Hoppe A, Muller I, Ebert M, Weng H, Holzhutter HG, Zanger UM, Bode J, Vollmar B, Thomas M, Dooley S. Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice. BMC Syst Biol 2015;9:83
2. Adams JM, Huppert KA, Castro EC, Lopez MF, Niknejad N, Subramanian S, Zarrin-Khameh N, Finegold MJ, Huppert SS, Jafar-Nejad H. Sox9 is a modifier of the liver disease severity in a mouse model of Alagille syndrome. Hepatology 2020;71:1331–1349
3. Clotman F, Jacquemin P, Plumb-Rudewiez N, Pierreux CE, Van der Smissen P, Dietz HC, Courtoy PJ, Rousseau GG, Lemaigre FP. Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev 2005;19:1849–1854
4. Coffinier C, Gresh L, Fiette L, Tronche F, Schutz G, Babinet C, Pontoglio M, Yaniv M, Barra J. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development 2002;129:1829–1838
5. Ferreira S, Devadason D, Denvir L, Seale A, Gupte G. GATA6 mutation: a rare genetic cause of hepatobiliary disease. J Pediatr Gastroenterol Nutr 2017;64:e134–e135
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献